UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.01B |
| 2 |
Microsoft
MSFT
|
+$922M |
| 3 |
Amazon
AMZN
|
+$646M |
| 4 |
Tesla
TSLA
|
+$554M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$496M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$1.04B |
| 2 |
Linde
LIN
|
+$949M |
| 3 |
ExxonMobil
XOM
|
+$313M |
| 4 |
VMW
VMware, Inc
VMW
|
+$217M |
| 5 |
NVIDIA
NVDA
|
+$205M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.4% |
| 2 | Healthcare | 13.37% |
| 3 | Consumer Discretionary | 11.23% |
| 4 | Financials | 10.99% |
| 5 | Communication Services | 8.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1651
PTC Therapeutics
PTCT
$5.68B
| $1.7M | ﹤0.01% |
75,726
+2,236
| +3% | +$83.2K |
|
1652
Core Laboratories
CLB
$488M
| $1.7M | ﹤0.01% |
70,671
+11,234
| +19% | +$276K |
|
1653
Enova International
ENVA
$6.33B
| $1.69M | ﹤0.01% |
33,233
-6,845
| -17% | -$357K |
|
1654
La-Z-Boy
LZB
$1.58B
| $1.69M | ﹤0.01% |
54,676
+7,084
| +15% | +$218K |
|
1655
Federal Agricultural Mortgage
AGM
$2.47B
| $1.69M | ﹤0.01% |
10,934
+1,101
| +11% | +$178K |
|
|
MDRX
1656
DELISTED
Veradigm Inc. Common Stock
MDRX
| $1.69M | ﹤0.01% |
128,298
-27,452
| -18% | -$360K |
|
|
HEES
1657
DELISTED
H&E Equipment Services
HEES
| $1.68M | ﹤0.01% |
38,978
+4,971
| +15% | +$227K |
|
1658
Perdoceo Education
PRDO
$1.99B
| $1.68M | ﹤0.01% |
98,301
-14,363
| -13% | -$219K |
|
|
AGNT
1659
AGNT Inc
AGNT
$666M
| $1.68M | ﹤0.01% |
103,475
+27,258
| +36% | +$562K |
|
1660
BioCryst Pharmaceuticals
BCRX
$2.28B
| $1.67M | ﹤0.01% |
236,561
| – | – |
|
1661
BGC Group
BGC
$5.45B
| $1.67M | ﹤0.01% |
316,608
| – | – |
|
1662
JFrog
FROG
$9.66B
| $1.67M | ﹤0.01% |
65,815
+18,100
| +38% | +$502K |
|
1663
The Bancorp
TBBK
$2.79B
| $1.66M | ﹤0.01% |
48,182
+3,390
| +8% | +$123K |
|
1664
US Physical Therapy
USPH
$1.2B
| $1.64M | ﹤0.01% |
17,925
-1,073
| -6% | -$115K |
|
1665
Twist Bioscience
TWST
$5.7B
| $1.64M | ﹤0.01% |
80,835
+32,287
| +67% | +$709K |
|
1666
St. Joe Company
JOE
$3.54B
| $1.64M | ﹤0.01% |
30,142
+3,329
| +12% | +$192K |
|
|
ZUO
1667
DELISTED
Zuora, Inc.
ZUO
| $1.62M | ﹤0.01% |
196,870
+2,063
| +1% | +$20.3K |
|
1668
Moog Inc Class A
MOG.A
$12.4B
| $1.62M | ﹤0.01% |
14,344
| – | – |
|
1669
Recursion Pharmaceuticals
RXRX
$1.59B
| $1.62M | ﹤0.01% |
211,576
+96,298
| +84% | +$961K |
|
1670
WaFd
WAFD
$2.72B
| $1.62M | ﹤0.01% |
63,125
-1,799
| -3% | -$50.3K |
|
1671
Cal-Maine
CALM
$4.12B
| $1.61M | ﹤0.01% |
33,294
-11,149
| -25% | -$518K |
|
1672
Hilltop Holdings
HTH
$2.26B
| $1.61M | ﹤0.01% |
56,842
-8,926
| -14% | -$269K |
|
|
PMT
1673
PennyMac Mortgage Investment
PMT
$822M
| $1.61M | ﹤0.01% |
129,782
+7,657
| +6% | +$100K |
|
1674
Middlesex Water
MSEX
$1.08B
| $1.6M | ﹤0.01% |
24,210
+832
| +4% | +$64.1K |
|
1675
Horace Mann Educators
HMN
$2.1B
| $1.59M | ﹤0.01% |
54,148
+571
| +1% | +$16.6K |
|
Similar funds
UBS AM's Q3 2023 Portfolio in Review
As of Q3 2023, UBS AM held 2,762 positions worth $223B, up 8.1% from $206B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
UBS AM deployed $7.28B of net new capital in Q3 2023, opening 89 new positions and adding to 1,400 existing holdings. Its largest new stake was Kenvue: 8,680,819 shares worth $174M.
By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 28% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Abbott, an estimated $1.04B trimmed.
- UBS AM's largest Q3 2023 buy was Kenvue: 8,680,819 shares worth $174M.
- UBS AM added most to Apple in Q3 2023, an estimated $1.01B increase.
- UBS AM's biggest Q3 2023 reduction was Abbott, cutting an estimated $1.04B.
- UBS AM fully exited World Wrestling Entertainment in Q3 2023, selling an estimated $128M.
- UBS AM's ten largest holdings make up 26% of its $223B portfolio in Q3 2023.
- UBS AM opened 89 new positions and closed 174 in Q3 2023.
- UBS AM's portfolio value rose 8.1% quarter-over-quarter to $223B.
Based on UBS AM's 13F filing for Q3 2023, filed 13 Nov 2023.